title: Hybrid quantum dot-fatty ester stealth nanoparticles: toward clinically relevant in vivo optical imaging of deep tissue.
abstract: Despite broad applications of quantum dots (QDs) in vitro, severe toxicity and dominant liver uptake have limited their clinical application. QDs that excite and emit in the ultraviolet and visible regions have limited in vivo applicability due to significant optical interference exerted by biological fluids and tissues. Hence we devised a new biocompatible hybrid fluorophore composed of near-infrared-emitting PbSe quantum dots encapsulated in solid fatty ester nanoparticles (QD-FEN) for in vivo imaging. The quantum yield and tissue penetration depth of the QD-FEN were characterized, and their biological fate was examined in a breast tumor-bearing animal model. It was found for the first time that chemical modification of the headgroup of QD-encapsulating organic fatty acids was a must as these groups quenched the photoluminescence of PbSe nanocrystals. The use of fatty esters enhanced aqueous quantum yields of PbSe QDs up to ∼45%, which was 50% higher than that of water-soluble PbSe nanocrystals in an aqueous medium. As a result, a greater than previously reported tissue penetration depth of fluorescence was recorded at 710 nm/840 nm excitation/emission wavelengths. The QD-FEN had much lower short-term cytotoxicity compared to nonencapsulated water-soluble QDs. More importantly, reduced liver uptake, increased tumor retention, lack of toxic response, and nearly complete clearance of QD-FEN from the tested animals was demonstrated. With a combination of near-infrared spectral properties, enhanced optical properties,and significantly improved biosafety profile, this novel hybrid nanoparticulate fluorophore system demonstrably provides real-time, deep-tissue fluorescent imaging of live animals, laying a foundation for further development toward clinical application.
authors.affiliation: Leslie L. Dan Faculty of Pharmacy, University of Toronto, and Department of Medical Biophysics, University Health Network, Princess Margaret Hospital, 144 College Street, Toronto, Ontario, Canada, M5S 3M2.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Shuhendler
authors.forename: Preethy
authors.initials: P
authors.lastname: Prasad
authors.forename: Ho-Ka Carol
authors.initials: HK
authors.lastname: Chan
authors.forename: Claudia R
authors.initials: CR
authors.lastname: Gordijo
authors.forename: Behrouz
authors.initials: B
authors.lastname: Soroushian
authors.forename: Michael
authors.initials: M
authors.lastname: Kolios
authors.forename: Kui
authors.initials: K
authors.lastname: Yu
authors.forename: Peter J
authors.initials: PJ
authors.lastname: O'Brien
authors.forename: Andrew Michael
authors.initials: AM
authors.lastname: Rauth
authors.forename: Xiao Yu
authors.initials: XY
authors.lastname: Wu
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D005227:Fatty Acids / Q000737:chemistry* / Q000493:pharmacokinetics; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008856:Microscopy, Fluorescence / Q000379:methods*; D053769:Nanocapsules / Q000737:chemistry; D045663:Quantum Dots; D051381:Rats
chemical_list: D005227:Fatty Acids; D053769:Nanocapsules